Literature DB >> 9764839

Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs.

M B Schilli1, R Paus, A Menrad.   

Abstract

Chemotherapy-induced alopecia is thought to result from cytotoxic and apoptosis-related damage to the hair follicle. This study was designed to confirm whether keratinocyte apoptosis is indeed induced in growing (= anagen) hair follicles of C57 BL/6 mice after the injection of cyclophosphamide, using improved methods for histologic detection of apoptotic cells in murine skin. More importantly, we asked whether topical calcitriol-analogs are able to modulate cyclophosphamide-induced apoptosis in vivo, because there are conflicting reports on the effects of calcitriols on apoptosis in vitro. Anagen was induced in telogen mice on day 0 by depilation. Starting on day 5 post-depilation, the back skin of mice was topically treated with either 0.2 microg 1,25-dihydroxyvitamin D3, 2.0 microg calcipotriol, 0.02 microg KH 1060, or vehicle (ethanol) only. On the last day of treatment (i.e., day 9 post-depilation), all mice received 150 mg cyclophosphamide i.p. per kg as a single dose to induce alopecia, or vehicle (aqua dist.). Analysis of the treated skin by in situ-end labeling (using a modified terminal UTP nucleotide end labeling technique suitable for murine skin), by Hoechst 33342 stain, and by DNA electrophoresis on days 10 and 14, revealed the induction of massive apoptosis in cyclophosphamide-treated anagen hair bulbs, which was most prominent on day 10, whereas controls showed no follicular apoptosis. The calcitriol-pretreated groups demonstrated a significant reduction of apoptosis, with a maximal inhibition seen on day 14. This confirms that cyclophosphamide indeed induces massive keratinocyte apoptosis in anagen hair follicles, and provides evidence that topical calcitriol-analogs can suppress epithelial cell apoptosis in vivo. The mouse model employed here offers an excellent tool for dissecting the as yet poorly understood controls of keratinocyte apoptosis in situ and its pharmacologic manipulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9764839     DOI: 10.1046/j.1523-1747.1998.00350.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  Treatment for chemotherapy-induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain.

Authors:  Ranjitha Katikaneni; Tulasi Ponnapakkam; Hirofumi Suda; Shigeru Miyata; Joshua Sakon; Osamu Matsushita; Robert C Gensure
Journal:  Int J Cancer       Date:  2012-01-24       Impact factor: 7.396

2.  Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model.

Authors:  Ranjitha Katikaneni; Tulasi Ponnapakkam; Osamu Matsushita; Joshua Sakon; Robert Gensure
Journal:  Anticancer Drugs       Date:  2014-01       Impact factor: 2.248

Review 3.  Protection against chemotherapy-induced alopecia.

Authors:  Jie Wang; Ze Lu; Jessie L-S Au
Journal:  Pharm Res       Date:  2006-11       Impact factor: 4.200

Review 4.  A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.

Authors:  Christopher John Dunnill; Wafaa Al-Tameemi; Andrew Collett; Iain Stuart Haslam; Nikolaos Theodoros Georgopoulos
Journal:  Oncologist       Date:  2017-09-26

5.  Laminin-511, inducer of hair growth, is down-regulated and its suppressor in hair growth, laminin-332 up-regulated in chemotherapy-induced alopecia.

Authors:  Hisayoshi Imanishi; Daisuke Tsuruta; Chiharu Tateishi; Koji Sugawara; Ralf Paus; Tsutomu Tsuji; Masamitsu Ishii; Kazuo Ikeda; Hiroyuki Kunimoto; Koichi Nakajima; Jonathan C R Jones; Hiromi Kobayashi
Journal:  J Dermatol Sci       Date:  2010-02-16       Impact factor: 4.563

6.  The α-lipoic acid derivative sodium zinc dihydrolipoylhistidinate reduces chemotherapy-induced alopecia in a rat model: a pilot study.

Authors:  Satoshi Hagiwara; Tomohisa Uchida; Hironori Koga; Masafumi Inomata; Fumitaka Yoshizumi; Masatsugu Moriyama; Seigo Kitano; Takayuki Noguchi
Journal:  Surg Today       Date:  2011-05-01       Impact factor: 2.549

7.  Preventive effect of edaravone ointment on cyclophosphamide-chemotherapy induced alopecia.

Authors:  Katsuaki Yoneda; Miyu Fujii; Aoi Imaoka; Remi Kobayashi; Ryoya Hayashi; Yuya Yoshida; Takeyuki Kohno; Takumi Tsuji
Journal:  Support Care Cancer       Date:  2021-04-02       Impact factor: 3.603

8.  Prevention of chemotherapy-induced alopecia in rodent models.

Authors:  Joaquin J Jimenez; Stephen M Roberts; Jessica Mejia; Lucia M Mauro; John W Munson; George W Elgart; Elizabeth Alvarez Connelly; Qingbin Chen; Jiangying Zou; Carlos Goldenberg; Richard Voellmy
Journal:  Cell Stress Chaperones       Date:  2008-02-05       Impact factor: 3.667

9.  Suppression of eukaryotic initiation factor 4E prevents chemotherapy-induced alopecia.

Authors:  Zeina Nasr; Lukas E Dow; Marilene Paquet; Jennifer Chu; Kontham Ravindar; Ragam Somaiah; Pierre Deslongchamps; John A Porco; Scott W Lowe; Jerry Pelletier
Journal:  BMC Pharmacol Toxicol       Date:  2013-11-13       Impact factor: 2.483

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.